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SUMMARY 
The catalepsy produced by bulbocapnine， perphenazine， and reserpine was 
studied using a simple new method. The apparatus was made as fo11ows: a vertica1 
po1e was made from the wooden square timbers measuring 0.7 cm wide，and an a1umi-
nium bar measuring 22 cm 10ng and 0.2 cm in diameter was positioned at a height 
of 20 cm between the timbers. The mouse was hung by the forearm in the center 
of the bar. The time difference was measured before and after medication that it 
took a mouse to travel across the bar from the hanging place to the vertical pole. 
Results of this experiment were analyzed by “t" and "chi-sq uare" tests. The 
advantage of this method was that it di町erentiatedbetween cata1eptic and paralytic 
reaction produced by the drugs. 
Keywords: Catalepsy，Mouse，Bulbocapnine，Perphenazine，Reserpine. 
These difficulties，however，were partially depend 
INTRODUCTlON 
on inadequency of the screening methods. The1'e 
Parkinson-Like symptoms are frequently in- are many methods available to study catalepsy 
duced by such drugs as tremorine，oxotremorine， in anima1s，such as those used in experiments 
reserpine，phenothiazine derivatives，bulbocap- by Courvoisier et aII>，Wirth et aF>，Zetle1' et 
sim ple ，Previousl y•and l'vIorpu 1' ug05l り，aP>has not ，however，Catalepsynine and others. 
been as well studied by pharmacologists as screening methods fo1' catalepsy were used such 
tremor produced by tremorine and other drugs. as hanging the mouse on the edge of a glass. 
Recently in this decade，L-DOPA has been em- B1'ucke6>，describing bulbocapnine-catalepsy in 
p10yed in the treatment of akinesia and rigidity mice，used a technique of hanging the mouse by 
associated with Parkinson's syndrome. The ef- his forea1'm on st1'etched fiber of woolen yarn. 
fects of L・DOPAon these symptoms were ac- Zetler3>り usedhis method with statistica1 analy-
curately described clinicaUy but it was di自 cult sis fo1' mice. This method was convenient for 
to reproduce these effects by anima1 experiments. the study of catalepsy，but the experimenter was 
These difficulties were chiefly attributed to the often to be tired fo1' too simple repeating action 
fact that drug induced catalepsy was di町erent in this method. 
from one observed in the human parkinsonism. The author's new method described in this 
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report was designed after the modification of 
Brucke's methodの in order to properly apply 
a statistical analysis. Catalepsy induced by 
bulbocapnine， reserpine and phenothozines were 
studied in this report. 
MATERIALS AND METHODS 
All experiment were carried out using the 
white d. d. strain of male mice weighing between 
16 and 22 g. All drugs were prepared in a physio-
logical saline solution and administered intra-
peritoneally in volume of 0.1 ml/l0 g of body 
weight. The drugs used in this experiment were 
bulbocapnine hydrochloride，perphenazine hydro-
chloride， sodium phenobarbital， meprobamate 
and reserpine. Ten mice were used for each 
.dose of a drug 
The apparatus is as follows: Vertical poles 
were made from two wooden square timbers， 
0.7 cm wide， and an aluminium bar， 22 cm long 
and 0.2 cm wide， was positioned at a height 20 
cm between these timbers. The mouse was hung 
by the forearm in the center of the bar. (Fig. 1). 
The test for catalepsy was characterized by 
measuring the time that the mouse passed along 
the bar from the hanging place to the vertical 
pole. (Fig. 2) Differences in time before and 
after the medication were measured. If the 
mouse fell before reaching the vertical pole，the 
time of the fall was recorded， and the sign “↓" 
Fig. 2. Mouse re.ached the pole. 
was added beside the time in the record (Table 
1). Trials were carried out before and after 
medication. Except fo1' reserpine， the time in-
terval of trial between before and after the medi-
cation was 30 min. For studies on 1' eserpine， 
the time interval was 90 min. 
The same animal was tested by Zetler's method， 
and the results were compared to those obtained 
gml/l0(0.1Results of saline injection. 1. Tab. 
intraperitoneal injection) 
Author's method 1刷 er' method 
No. B.W. 
g 
Difference 
Before 30 min after before and 
injection the injection after medi-
cation 
Positive 
result 
16 
2 16 
3 17 
4 16 
5 15 
6 18 
7 16 
8 16 
9 17 
10 16 
3 sec ↓ 15 sec 12 sec 
12" 10" -2" 
14" 4" -10" 
ら" 9" 3" 
9" 23" 14" 
19" 16" -3" 
7" 29" 22" 
21" 19" -3" 
7" 5" -2" 
17" 22" 5" 
2 
。
。。
。。。
X 11.5" 15.2" 3.6" 
6.1" 8.2" 8.7"。 
0.5 
0.88 
B.W.=Body weight ↓ =Fall 
=Arithmeticmean. 文 1. Fig. Mouse hanged with his forearms on s=Standard deviation. 
the bar. "=sec 
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experi-1' All resu1ts 0by the author's method. 
ments were analyzed by the “ t" and “ chi-
square" tests. 
RESULTS 
The e町 ectsof injection of ph ysio1ogica1 sa1ine 
sol u tion at 0.1 mlj 1 0 g inmice were tested by the 
author's and by Zet1er's method. Recorded the 
mean time of each tria1 by the author's method 
were 1し 5土 6.1 sec before the medication， and 
15.8土 8.2sec after the medication， average dif-
ference between before and after was 3.6士 8.7 
sec. The number of falls was one before medi-
cation and Zero after the medication. (Tab1e 1) 
positive resu1ts obtained 1' The mean numbe1' 0
by Zetler's method was 0.5 :t 0.88. (Tab1e 1) 
The ave1' age di官 e1' ences between before and 
afte1' injection of bu1bocapnine wc1' e 0.5土 9.9sec 
at a dose leve1 of 20 mgjkg， 119.2:t 103.8 sec at 
a dose level of 4-0 mgjkg， and 60.4-土 99.2sec at 
a dose level of 80 mgjkg. The number of falls 
we1' e Ze1' o both befo1' e and afte1' injection of 20 
mgjkg， one befo1' e and one afte1' injection of 4-0 
mgjkg， and 2 before and 10 afte1' injection of 80 
mgjkg of bulbocapnine. 
The mean numbe1' of positive 1' esults after in・ 
jection of bu1bocapnine by Zetlel"s method we1' e 
1. 8士1. 6at a dose level of 20 mgjkg， 4-.4-:t 1. 8 at 
a dose level of 4-0 mgjkg， and 8.1土 2.5at a dose 
:tand 8.1 ，0 mgjkg4-level of 2.5 at a dose levelof 
80 mgjkg. 
There we1' e statistically significant diffe1' ences 
between the saline injected cont1' ols and those 
injected with 4-0 mgjkg of bulbocapnine by au・ 
tho1" s method (Pく 0.05). The1' e were also simi・ 
lar differences in the number of falls before and 
after the medication using a dose of 80 mgjkg. 
The1' e we1' e statistically a difference and a 
significant difference before and after medica-
tions between the saline controls and the in・ 
jection of bulbocapnine at a dose levels of 20 
80 mgjkg 1' 0，0.05)く0 mg/kg (P4-，0.1)くmg/kg (P 
(Pく 0.05)by Zetler's method. (Table 2) 
rhenseveral doses of reserpine we1' e given 、へ 
Tab. 2. Resu1ts of bulbocapnine injection. 
(Avarage va1ues in 10 mice) 
Dose mg/kg 20 4-0 80 
X 0.5" 119.2"骨骨 60.4-
and after medication s 9.9" 103.8" 99.2" 
by author・'smethocl 
Difference before 
↓ B/A 010 1/1 2/10時 
Positive result by X 1. 8枠 4.4持持 8.11時 
Zetler's methocl 1. 6 1. 8 2.5 
↓ =Fall 

B =Number before medication. 

A =Number after medication. 

又= Arithmetic mean. 

s = Standard deviation. 

"=sec 

長 =P>O.1 1 
・開 :P>O:O5t Probab 仙 y of statistical 句 lifiωlt 
di町 erencebetween saline and bu1-
bocapnine. 
intraperitoneally， the avcrage di町 erencesbetween 
before and after the medication were 11. 7土 12.4-
sec at a dose leve1 of 0.125 mgjkg， 65.8:t 81. 8 sec 
at a dose level of 0.65 mg/kg， 171. 8:t 97.9 sec at 
a dose level of 1. 25 mg/kg， 19.8:t4-3.2 sec at a 
dose level of 2.5 mg/kg and 12.9:t 18.9 sec at a 
dose level of 5 mgjkg. Ave1' age di町 erences in 
values between saline controls and mice injected 
with 0.65 mgjkg of 1' eserpine were statistically 
different (Pく 0.1). There was also statistically 
significant difference between the saline controls 
and mice injected with reserpine at a dose of 
1. 25 mgjkg. (Pく 0.05) The differences in the 
number of falls before and after injection of 2.5 
mg or 4-mgjkg of reserpine were statistically 
significant (Pく 0.05). 
The mean numbers of positive results by 
Zet1er's method were 1. 1土1. 9at a dose level of 
0.125 mgjkg， 3.8:t4-.5 at a dose level of 0.65 mgj 
土6.9，25 mgjkg1.at a dose level of .14-:t8.5，kg 
4.3 at a dose level of 2.5 mgjkg and 2.6土 2.7 at 
a dose of 5 mgjkg. There were statistically a 
difference and a significant difference between 
the saline control ancl those inJected with of 0.65 
mg， 5 mgjkg (Pく 0.1)ancl 1. 25 mg ancl 2.5 mg/kg 
of reserpine (Pく 0.05).(Table 3) 
When several doses of pe1' phenazine were given 
intraperiotoneally， the average differences be-
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Tab. 3. Results of reserpine injection. 
(Avarage values in 10 mice) 
Dose mg/kg 
Difference before 
and after medication 
by author's method 
X 0.125 0.65 1. 25 2.5 5.0 
X 
↓B/A 
11. 7" 
12.4" 
65.8"長 
81. 8" 
171. 8"骨骨 
97.9" 
1/2 
19.8" 
43.2" 
0/5骨骨 
12.9" 
18.9" 
0/5苦骨 
Positive result by x 1. 1 3.8持 8.5脅特 6.9脅勢 2.6骨 
Zetler's method s 1. 9 4.5 4.1 4.3 2.7 
↓ =Fall 

B =Number before medication. 

A =Number after medication. 

ま= Arithmetic mean. 

s = Standard deviation. 

"=sec 

ificantdifference between 叩ofstatistica1 川i凶E315)Proょこ 
saline and reserpine. 
Tab. 4. Results of perphenazine injection. 
(Avarage va1ues in 10 mice) 
Dose mg/kg 
Difference before 
and after medication 
by author's method 
Positive result by 
Zetler's method 
0.6 1. 2 2.4 4.8 
x 12.0" 22.1 87.4" 242.0"長持 
s 3.2" 60.8" 190.1" 182.0" 
↓B/A 0/2 2/4 0/3 2/4 
x 1. 2 5.2帯後 7.8徒骨 10.3長勢 
s 1. 8 4.0 4.4 2.2 
↓ =Fall 
B =Number before medication. 
A = N umber after medication. 
x = Arithmetic mean. 
s = Standard deviation. 

"=sec 

骨骨 =Pく 0.05Probability of statistica1 significant difference between 
saline and perphenazine. 
tween before and after the medication were 12.0 
土 3.2sec at a dose 1eve1 of 0.6 mg/kg， 22.1土 60.8 
sec at a dose 1evel of 1. 2 mg/kg， 87.4土 190.1 sec 
at a dose level of 2.4 mg/kg and 242土 182sec at 
a dose leve1 of 4.8 mg/kg. There was a statisti-
cally significant difference between the saline 
control and injected with 4.8 mg/kg perphenazine 
(Pく 0.05). The differences in numbers of falls 
before and after administration of each dose of 
perphenazine were not satistically significant. 
The mean numbers of positive results by 
Zetler's method were 1. 2土1. 8at a dose level of 
0.6 mgJkg， 5.2土 4.0at a dose level of 1. 2 mg/kg， 
7.4土 4.4 at a dose leve1 of 2.4 mg/kg and 10.3土 
2.2 at a dose 1eve1 of 4.8 mg/kg. There were 
statistically significant differences between the 
saline controls and mice injected with 1. 2 mg， 
2.4 mg， and 4.8 mg/kg of perphenazine (Pく 0.05). 
(Table 4) 
When phenobarbital in various doses or at a 
dose 1eve1 of 40 mg/kg of meprobamate were in・ 
jected intraperitoneally， the average differences 
between before and after injection of pheno-
barbita1 or meprobomate were -4.3士 8.8sec at 
a dose level of 20 mg/kg， 4.1土 20.5sec at a dose 
1eve1 of 40 mgJkg， -11. 6土 11. 3sec at a dose 1evel 
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Tab. 5. Results of phenobarbital and meprobamate injection. 
(Avarage values in 10 mice) 
Phenobar・bital Meprobamate 
Dose mg/kg 
Di町 erercebefore 
and after medication 
by author's method 
20 40 80 40 
x -4.3" 4.1" -1 1.6 l岬 -4.6" 
s 8.8" 20.5" 11. 3" 13.2" 
↓ B/A 2/4 0/8骨骨 2/10柑 3/3 
Positive result by x 0.3 0.2 0.3 4.2骨 
Zetler's method s 9.9 0.5 0.67 4.4 
↓ =Fall 
B =Number before medication. 
A =Number after medication. 
主 =Arithmeticmean. 
s=Standard deviation. 
"=sec 
勢;二:ミ~:65} Probability of statistical叩 ificantdiffer… between 
saline and phenobarbital or meprobamate. 
of 80 mg/kg of phenobarbital， and -4.6土 13.2sec 
at the dose level of 40 mgjkg of meprobamate. 
There was a statistical difference between the 
saline control and injected with 80 mgjkg of 
phenobarbital (Pく 0.1). The differences in the 
numbers of falls before and after injection of 40 
mg， and 80 mgJkg of phenobarbital， were statisti-
cally significant (Pく 0.05)， especiall y after injec-
tion of 80 mgjkg. Using this dose al mice fell 
in 1 sec. 
The mean numbers of positive results by 
Zetle1" s method were 0.3:t 0.9 at a dose level of 
20 mgJkg， 0.2:t 0.5 at a dose level of 40 mgJkg and 
0.3土 0.67at a dose level of 80 mgJkg of pheno・ 
ba1' bital， and 4.2:t 4.4 at a dose level of 40 mgJ 
kg of mep1' obamate. Statistically there was a 
difference between the saline controls and in-
jected with 40 mgJkg of meoprobamate (Pく 0.1). 
(Table 5) 
DISCUSSION 
In this study， seve1' al kinds of cent1' al acting 
d1' ugs we1' e tested fo1' catalepsy activity in mice. 
The method included measurements of time 
necessa1' y fo1' mice either to reach vertical poles 
or fall f1' om the bar when positioned in the 
center of a horizontal ba1'. Results of these ex・ 
periments were compared with those of Zetler's 
method3内 . Although results of tests are not 
compatible with those obtained in clinical parkin-
sonism， they indicate the presence or absence of 
catalepsy in animals， which resembles parkin-
sonlsm ln man. 
The primary objective of this study was to 
find a simple screening method whjch would 
enable us to c1 assify the reactions to drugs as 
cataleptic or paralytic. For this purpose， the 
author carried out experiments and compared 
the results with the results by Zetlers' method. 
For example， in bulbocapnine-induced cata-
lepsy， only the injection of 40 mgJkg of this 
drug produced statistically significant differences 
by author's method， but after injection of 20 mg 
/kg， 40 mg/kg and 80 mgJkg statistically signifi~ 
cant di官 erenceswere obtained by Zetler's meth-
od. These differences in results between the 
author's and Zetler's methods after the injection 
of 80 mgJkg of bulbocapnine， were attributed to 
the abi1 ity of the method to react with an in-
itial paralysis. This fact is demonstrated by the 
statistically significant increase in numbers of 
falls， and this increase is the sign of a pa1' alytic 
reaction. The differences in 1' esults， after in-
jection of 20 mgjkg of bulbocapnine， between 
the author's and Zetler's method， w i1l be dis-
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cussed later when comparing reaction produced 
by meprobamate. The effect of injection of 1.25 
mgjkg of reserpine，was statistically significant 
by the author's method. The injection of 1.25 
mgjkg，2.5 mgjkg and 5 mgJkg of reserpine pro-
duced a statistically significant difference by 
Zetler's method. However by the author's meth-
od，the number of falls was statistical signiι 
cantly increased after injection of 2.5 mgJkgand 
5 mgJkg reserpine. The difference in time before 
and after the medication by the author's method 
was markedly decreased after injection of 2.5 
mgJkg and 5 mg/kg reserpine. Paralytic reac-
tions were found by these doses using the au・ 
thor's method. This indicates that the author's 
method was superior to Zetler's method，since 
perception of the paralytic reaction was evident 
using bulbocapine. 
The effects of multiple doses of perphenazine 
differ from the effects produced by bulbocapnine 
and reserpine. Only results of injection of 4.8 
mgJkg by the author's method produced a stati-
stically significant difference，but the results of 
injection of 1.2 mgJkg，2.4mgjkg and 4.8 mgJkg， 
also gave statistically significant differences by 
Zetler's method. Morpurgo5) described injection 
of 5 mgJkg of perphenazine as producing con-
stantly maximal catalepsy，and the results of 
the author's method agreed with his report. 
Using Zetler's method catalepsy was produced 
by lower doses of drug. The reason for this 
result depends upon the variations seen in the 
reactions of drugs by the author's method. This 
was especially true in ，the increases of falls，and 
the results were not statistically significant. The 
fall type produced by perphenazine was not simi-
lar to types produced by other drugs，the fall 
type produced perphenazine was seemed as if 
jump down. There may have been a hyper-
kinetic e町'ectproduced before catalepsy. 
1n additional experiments conducted using seve-
ral doses of phenobarbital and one dose of 
meprobamate，the authors could not find any 
increase in the time difference before and after 
administration of either drug. An increase in 
the number of falls was found by injection of 
40 mgJkg and 80 mgjkg of phenobarbital，and the 
reaction appeared to be paralytic. Phenobarbi-
tal tested by Zetlet.，s method could not find a 
paralytic reaction，in the numbers of positive 
results. Further study on paralytic effects of 
other drugs will be investigated by author' 
method compared with other method. 
Of the number of positive results by Zetler's 
method，there were statistically significant dif・ 
ferences between the injection of 40 mgJkg of 
meprobamate and the injection of saline. This 
result suggests that the sedative reaction could 
be mistaken at times as catalepsy by Zetler's 
method. The injection of 20 mgjkg of bulbo-
capnine may have produced a sedative reaction 
in mice，and it seems to be a catalepsy by 
Zetler's method. 
CONCLUSIONS 
Using results of experiments by a new method 
for measuring catalepsy in mice，the following 
conclusions were made: 
This method is simple，the results can be 
analyzed satistically，and the appearance of a 
paralytic reaction can be eliminated accurately. 
Bulbocapnine produced the most typical cata-
lepsy after injection at a dose level of 40 mgJkg， 
and the appearance of the paralytic reaction 
was seen by the injection of 80 mgJkg. 
Reserpine also produced a typical catalepsy 
after injection of 1.25 mg/kg，and in greater 
doses，a paralytic reaction was produced. 
Perphenazine produced typical catalepsy by 
the injection of 4.8 mgjkg. 
By Zetler's method，a sedative reaction could 
be mistaken for catalepsy，and the appearance 
of a paralytic reaction was not as precise as 
the author's method. 
まとめ
マウスを用いてブ、Jレボカプニン，パ{フェナクン，レセ
ノレピン等によって起こるカタレプシーを測定する簡易な
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方法を新しく考案した。装置は一辺 0.7 CI11の支柱を 2

本垂直に立て，その支柱の高さ 20CI11の所に長さ 22CI1，

直径 0.2cmのアルミニウム製の棒を渡したものである。

このアルミニウム俸の中央にマウスをその前肢でぶら下

らせ，ぶら下らせてから支柱にたどりつくまでか，落下

するまでの時間を測定した。投薬前と投薬後のこの時間

の差を計算し 10匹のマウスの平均値と標準偏差を求め，

投薬した薬の量と種類それぞれを，生理食塩水注射の値

と比較し統計心理を行なった。同時に同じ動物で Zetler
の方法による陽性値も測定し，筆者の方法と比較検討し
た。
この方法は Zetlerの方法に比べ，カタレプシー症状
と麻庫症状の発現を区別できる点などでよりすぐれてい
るものと考える。 
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